Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation

Abstract

Rationale

Accumulating evidence indicates that the mixed serotonin and dopamine receptor agonist lysergic acid diethylamide (LSD) induces an altered state of consciousness that resembles dreaming.

Objectives

This study aimed to test the hypotheses that LSD produces dreamlike waking imagery and that this imagery depends on 5-HT2A receptor activation and is related to subjective drug effects.

Methods

Twenty-five healthy subjects performed an audiorecorded guided mental imagery task 7 h after drug administration during three drug conditions: placebo, LSD (100 mcg orally) and LSD together with the 5-HT2A receptor antagonist ketanserin (40 mg orally). Cognitive bizarreness of guided mental imagery reports was quantified as a standardised formal measure of dream mentation. State of consciousness was evaluated using the Altered State of Consciousness (5D-ASC) questionnaire.

Results

LSD, compared with placebo, significantly increased cognitive bizarreness (p < 0.001). The LSD-induced increase in cognitive bizarreness was positively correlated with the LSD-induced loss of self-boundaries and cognitive control (p < 0.05). Both LSD-induced increases in cognitive bizarreness and changes in state of consciousness were fully blocked by ketanserin.

Conclusions

LSD produced mental imagery similar to dreaming, primarily via activation of the 5-HT2A receptor and in relation to loss of self-boundaries and cognitive control. Future psychopharmacological studies should assess the differential contribution of the D2/D1 and 5-HT1A receptors to cognitive bizarreness.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3

Notes

  1. 1.

    As this meditative state progresses, subjects experience a “quasi-reality” with its concomitant feelings and associated affects, which was termed “catathymic imagery” by Leuner (1969).

References

  1. Abramson HA, Jarvik ME, Kaufman MR, Kornetsky C, Levine A, Wagner M (1955) Lysergic acid diethylamide (LSD-25): I. Physiological and perceptual responses. The Journal of Psychology 39(1):3–60. doi:10.1080/00223980.1955.9916156

    CAS  Article  Google Scholar 

  2. Achermann P, Rusterholz T, Dürr R, König T, Tarokh L (2016) Global field synchronization reveals rapid eye movement sleep as most synchronized brain state in the human EEG. Royal Society Open Science 3(10):160201. doi:10.1098/rsos.160201

  3. Amargós-Bosch M, Bortolozzi A, Puig MV, Serrats J, Adell A, Celada P, Mengod G, Artigas F, Toth M (2004) Co-expression and in vivo interaction of serotonin 1A and serotonin 2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex 14(3):281–299. doi:10.1093/cercor/bhg128

    PubMed  Article  Google Scholar 

  4. Araneda R, Andrade R (1991) 5-Hydroxytryptamine 2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience 40(2):399–412. doi:10.1016/0306-4522(91)90128-B

    CAS  PubMed  Article  Google Scholar 

  5. de Araujo DB, Ribeiro S, Cecchi GA, Carvalho FM, Sanchez TA, Pinto JP, de Martinis BS, Crippa JA, Hallak JEC, Santos AC (2012) Seeing with the eyes shut: neural basis of enhanced imagery following ayahuasca ingestion. Hum Brain Mapp 33(11):2550–2560. doi:10.1002/hbm.21381

    PubMed  Article  Google Scholar 

  6. Baggott MJ (2015) Psychedelics and creativity: a review of the quantitative literature. PeerJ PrePrints 3:e1202v1. doi:10.7287/peerj.preprints.1202v1

  7. Baggott MJ, Siegrist JD, Galloway GP, Robertson LC, Coyle JR, Mendelson JE (2010) Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans. PLoS One 5(12):e14074. doi:10.1371/journal.pone.0014074

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  8. Ballanger B, Strafella AP, van Eimeren T, Zurowski M, Rusjan PM, Houle S, Fox SH (2010) Serotonin 2A receptors and visual hallucinations in Parkinson disease. Arch Neurol 67(4):416–421. doi:10.1001/archneurol.2010.35

    PubMed  Article  Google Scholar 

  9. Braun A (1997) Regional cerebral blood flow throughout the sleep-wake cycle. An H2(15)O PET study. Brain 120(7):1173–1197. doi:10.1093/brain/120.7.1173

    PubMed  Article  Google Scholar 

  10. Bressloff PC, Cowan JD, Golubitsky M, Thomas PJ, Wiener MC (2002) What geometric visual hallucinations tell us about the visual cortex. Neural Comput 14(3):473–491. doi:10.1162/089976602317250861

    PubMed  Article  Google Scholar 

  11. Busch AK, Johnson WC (1950) LSD 25 as an aid in psychotherapy; preliminary report of a new drug. Diseases of the nervous system 11(8):241–243

    CAS  PubMed  Google Scholar 

  12. Carhart-Harris R, Nutt D (2014) Was it a vision or a waking dream? Front Psychol 5:255. doi:10.3389/fpsyg.2014.00255

    PubMed  PubMed Central  Article  Google Scholar 

  13. Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, Tagliazucchi E, Schenberg EE, Nest T, Orban C, Leech R, Williams LT, Williams TM, Bolstridge M, Sessa B, McGonigle J, Sereno MI, Nichols D, Hellyer PJ, Hobden P, Evans J, Singh KD, Wise RG, Curran HV, Feilding A, Nutt DJ (2016) Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proc Natl Acad Sci U S A 113(17):4853–4858. doi:10.1073/pnas.1518377113

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  14. Carter OL, Burr DC, Pettigrew JD, Wallis GM, Hasler F, Vollenweider FX (2005) Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. J Cogn Neurosci 17(10):1497–1508. doi:10.1162/089892905774597191

    PubMed  Article  Google Scholar 

  15. Celada P, Puig MV, Amargós-Bosch M, Adell A, Artigas F (2004) The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 29(4):252–265

    PubMed  PubMed Central  Google Scholar 

  16. Chandler AL, Hartman MA (1960) Lysergic acid diethylamide (LSD-25) as a facilitating agent in psychotherapy. Arch Gen Psychiatry 2(3):286–299. doi:10.1001/archpsyc.1960.03590090042008

    Article  Google Scholar 

  17. Dammann G, Dürsteler-Macfarland KM, Strasser H, Skipper GE, Wiesbeck GA, Wurst FM (2014) Cannabis use among a sample of 16 to 18 year old students in Switzerland. Psychiatr Danub 26(1):56–65

    PubMed  Google Scholar 

  18. Dittrich A (1996) Aetiologie-unabhängige Strukturen veränderter Wachbewusstseinszustände: Ergebnisse empirischer Untersuchungen über Halluzinogene I. Und II. Ordnung, sensorische Deprivation, hypnagoge Zustände, hypnotische Verfahren sowie Reizüberflutung. VWB, Berlin

    Google Scholar 

  19. Dolder PC, Schmid Y, Haschke M, Rentsch KM, Liechti ME (2015) Pharmacokinetics and concentration-effect relationship of oral LSD in humans. Int J Neuropsychopharmacol 19(1):1–7. doi:10.1093/ijnp/pyv072

    Google Scholar 

  20. Driver H, Flanigan M, Bentley A, Mitchell D, Luus H, Shapiro C (1995) The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects. Psychopharmacology 117(2):186–192. doi:10.1007/BF02245186

    CAS  PubMed  Article  Google Scholar 

  21. Ermentrout G, Cowan J (1979) A mathematical theory of visual hallucination patterns. Biol Cybernetics 34(3):137–150. doi:10.1007/BF00336965

    CAS  Article  Google Scholar 

  22. Ettrup A, Cunha-Bang SD, Mcmahon B, Lehel S, Dyssegaard A, Skibsted AW, Jørgensen LM, Hansen M, Baandrup AO, Bache S, Svarer C, Kristensen JL, Gillings N, Madsen J, Knudsen GM (2014) Serotonin 2A receptor agonist binding in the human brain with [11C] Cimbi-36. J Cereb Blood Flow Metab 34(7):1188–1196. doi:10.1038/jcbfm.2014.68

  23. Family N, Vinson D, Vigliocco G, Kaelen M, Bolstridge M, Nutt DJ, Carhart-Harris RL (2016) Semantic activation in LSD: evidence from picture naming. Language, Cognition and Neuroscience 31(10):1320–1327. doi:10.1080/23273798.2016.1217030

    Article  Google Scholar 

  24. Fischer R, Landon GM (1972) On the arousal state-dependent recall of 'subconscious' experience: stateboundness. Br J Psychiatry 120(555):159–172. doi:10.1192/bjp.120.555.159

    CAS  PubMed  Article  Google Scholar 

  25. Fischman LG (1983) Dreams, hallucinogenic drug states, and schizophrenia: a psychological and biological comparison. Schizophr Bull 9(1):73–94. doi:10.1093/schbul/9.1.73

    CAS  PubMed  Article  Google Scholar 

  26. Fosse R, Stickgold R, Hobson JA (2004) Thinking and hallucinating: reciprocal changes in sleep. Psychophysiology 41(2):298–305. doi:10.1111/j.1469-8986.2003.00146.x

    PubMed  Article  Google Scholar 

  27. Franke GH, Derogatis LR (1995) Die Symptom-Checkliste von Derogatis SCL-90-R; deutsche Version; Manual. Beltz-Test-GmbH, Göttingen

    Google Scholar 

  28. Frecska E, Móré CE, Vargha A, Luna LE (2012) Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies. J Psychoactive Drugs 44(3):191–199. doi:10.1080/02791072.2012.703099

    PubMed  Article  Google Scholar 

  29. Frederking W (1955) Intoxicant drugs (mescaline and lysergic acid diethylamide) in psychotherapy. J Nerv Ment Dis 121(3):262–266

    CAS  PubMed  Article  Google Scholar 

  30. Giacomelli S, Palmery M, Romanelli L, Cheng C, Silvestrini B (1998) Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro. Life Sci 63(3):215–222. doi:10.1016/S0024-3205(98)00262-8

  31. Gillin J, Jernajczyk W, Valladares-Neto D, Golshan S, Lardon M, Stahl S (1994) Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers. Psychopharmacology 116(4):433–436. doi:10.1007/BF02247474

    CAS  PubMed  Article  Google Scholar 

  32. Glicksohn J (1992) An exploratory study of syncretic experience: eidetics, synaesthesia and absorption. Perception 21(5):637–642. doi:10.1068/p210637

    CAS  PubMed  Article  Google Scholar 

  33. González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, Zhou Q, Sealfon SC, Gingrich JA (2007) Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior. Neuron 53(3):439–452. doi:10.1016/j.neuron.2007.01.008

    PubMed  Article  CAS  Google Scholar 

  34. Gottesmann C (2006) The dreaming sleep stage: a new neurobiological model of schizophrenia? Neuroscience 140(4):1105–1115. doi:10.1016/j.neuroscience.2006.02.082

    CAS  PubMed  Article  Google Scholar 

  35. Green WJ (1969) LSD and the sleep-dream cycle. Experimental medicine and surgery 27(1–2):138–144

    CAS  PubMed  Google Scholar 

  36. de Gregorio D, Posa L, Ochoa-Sanchez R, Mclaughlin R, Maione S, Comai S, Gobbi G (2016) The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors. Pharmacol Res 113:81–91. doi:10.1016/j.phrs.2016.08.022

    PubMed  Article  CAS  Google Scholar 

  37. Guilford JP (1967) The nature of human intelligence. McGraw-Hill, New York

    Google Scholar 

  38. Halberstadt AL (2015) Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behav Brain Res 277:99–120. doi:10.1016/j.bbr.2014.07.016

    CAS  PubMed  Article  Google Scholar 

  39. Halberstadt A, Geyer M (2010) LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor. Psychopharmacology 208(2):179–189. doi:10.1007/s00213-009-1718-x

    CAS  PubMed  Article  Google Scholar 

  40. Halberstadt AL, Geyer MA (2011) Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology 61(3):364–381. doi:10.1016/j.neuropharm.2011.01.017

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  41. Halgren E, Walter RD, Cherlow DG, Crandall PH (1978) Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala. Brain 101(1):83–115. doi:10.1093/brain/101.1.83

    CAS  PubMed  Article  Google Scholar 

  42. Hobson JA (2001) The dream drugstore: chemically altered states of consciousness. MIT Press, Cambridge

    Google Scholar 

  43. Hobson JA (2009) REM sleep and dreaming: towards a theory of protoconsciousness. Nature Reviews Neuroscience 10(11):803–813. doi:10.1038/nrn2716

    CAS  PubMed  Google Scholar 

  44. Jacobs B (1978) Dreams and hallucinations: a common neurochemical mechanism mediating their phenomenological similarities. Neurosci Biobehav Rev 2(1):59–69. doi:10.1016/0149-7634(78)90007-6

    CAS  Article  Google Scholar 

  45. Johnson MW, Richards W, Griffiths R (2008) Human hallucinogen research: guidelines for safety. J Psychopharmacol 22(6):603–620. doi:10.1177/0269881108093587

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  46. Kahn D (2013) Brain basis of self: self-organization and lessons from dreaming. Front Psychol 4(1):408. doi:10.3389/fpsyg.2013.00408

    PubMed  PubMed Central  Google Scholar 

  47. Kometer M, Schmidt A, Jäncke L, Vollenweider FX (2013) Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. J Neurosci 33(25):10544–10551. doi:10.1523/JNEUROSCI.3007-12.2013

    CAS  PubMed  Article  Google Scholar 

  48. Kometer M, Pokorny T, Seifritz E, Vollenweider FX (2015) Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. Psychopharmacology 232(19):3663–3676. doi:10.1007/s00213-015-4026-7

  49. Krebs-Thomson K, Geyer MA (1998) Evidence for a functional interaction between 5-HT1A and 5-HT2 receptors in rats. Psychopharmacology 140(1):69–74. doi:10.1007/s002130050740

    CAS  PubMed  Article  Google Scholar 

  50. LaBerge S, Rheingold H (1991) Exploring the world of lucid dreaming. Ballantine Books, New York

    Google Scholar 

  51. Lakoff G (1993) How metaphor structures dreams. Dreaming 3(2):77–98. doi:10.1037/h0094373

    Article  Google Scholar 

  52. Landon M, Fischer R (1970) On similar linguistic structures in creative performance and psilocybin-induced experience. Confinia psychiatrica 13(2):115–138

    CAS  Google Scholar 

  53. Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL (2015) Finding the self by losing the self: neural correlates of ego-dissolution under psilocybin. Hum Brain Mapp 36(8):3137–3153. doi:10.1002/hbm.22833

    PubMed  Article  Google Scholar 

  54. Leuner H (1968) Basic functions involved in the psychotherapeutic effect of psychotomimetics. In: Shlien JM (ed) Research in psychotherapy. American Psychological Association, Washington, pp 466–470

    Google Scholar 

  55. Leuner H (1969) Guided affective imagery (GAI). A method of intensive psychotherapy. Am J Psychother 23(1):4–21

    CAS  PubMed  Google Scholar 

  56. Leuner H (1973) Creativity and modification of consciousness. Confinia psychiatrica 16(3):141–158

    CAS  Google Scholar 

  57. Leuner H (1981) Halluzinogene. Hans Huber, Bern

    Google Scholar 

  58. Leysen JE, Niemegeers CJ, van Nueten JM, Laduron PM (1982) [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol 21(2):301–314

    CAS  PubMed  Google Scholar 

  59. Limosani I, D'Agostino A, Manzone ML, Scarone S (2011) Bizarreness in dream reports and waking fantasies of psychotic schizophrenic and manic patients: empirical evidences and theoretical consequences. Psychiatry Res 189(2):195–199. doi:10.1016/j.psychres.2011.02.023

    PubMed  Article  Google Scholar 

  60. Llinás R, Ribary U (1993) Coherent 40-Hz oscillation characterizes dream state in humans. Proc Natl Acad Sci U S A 90(5):2078–2081. doi:10.1073/pnas.90.5.2078

    PubMed  PubMed Central  Article  Google Scholar 

  61. Maquet P, Péters J, Aerts J, Delfiore G, Degueldre C, Luxen A, Franck G (1996) Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature 383(6596):163–166. doi:10.1038/383163a0

    CAS  PubMed  Article  Google Scholar 

  62. Marona-Lewicka D, Nichols DE (2007) Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action. Pharmacol Biochem Behav 87(4):453–461. doi:10.1016/j.pbb.2007.06.001

    CAS  PubMed  Article  Google Scholar 

  63. Marona-Lewicka D, Thisted RA, Nichols DE (2005) Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Psychopharmacology 180(3):427–435. doi:10.1007/s00213-005-2183-9

    CAS  PubMed  Article  Google Scholar 

  64. Martindale C, Fischer R (1977) The effects of psilocybin on primary process content in language. Confinia psychiatrica 20(4):195–202

    CAS  Google Scholar 

  65. Massimini M, Ferrarelli F, Murphy M, Huber R, Riedner B, Casarotto S, Tononi G (2010) Cortical reactivity and effective connectivity during REM sleep in humans. Cognitive neuroscience 1(3):176–183. doi:10.1080/17588921003731578

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  66. Mégevand P, Groppe DM, Goldfinger MS, Hwang ST, Kingsley PB, Davidesco I, Mehta AD (2014) Seeing scenes: topographic visual hallucinations evoked by direct electrical stimulation of the parahippocampal place area. J Neurosci 34(16):5399–5405. doi:10.1523/JNEUROSCI.5202-13.2014

    PubMed  Article  CAS  Google Scholar 

  67. Meltzer HY, Li Z, Kaneda Y, Ichikawa J (2003) Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 27(7):1159–1172. doi:10.1016/j.pnpbp.2003.09.010

    CAS  Article  Google Scholar 

  68. Meltzer HY, Mills R, Revell S, Williams H, Johnson A, Bahr D, Friedman JH (2009) Pimavanserin, a serotonin2A receptor inverse agonist, for the treatment of Parkinson’s disease psychosis. Neuropsychopharmacology 35(4):881–892. doi:10.1038/npp.2009.176

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  69. Merz J, Lehrl S, Galster V, Erzigkeit H (1975) MWT-B: ein Intelligenzkurztest. Psychiatrie Neurologie und Medizinische Psychologie 27(7):423–428

    CAS  Google Scholar 

  70. Muthukumaraswamy SD, Carhart-Harris RL, Moran RJ, Brookes MJ, Williams TM, Erritzoe D, Sessa B, Papadopoulos A, Bolstridge M, Singh KD, Feilding A, Friston KJ, Nutt DJ (2013) Broadband cortical desynchronization underlies the human psychedelic state. J Neurosci 33(38):15171–15183. doi:10.1523/JNEUROSCI.2063-13.2013

  71. Muzio JN, Roffwarg HP, Kaufman E (1966) Alterations in the nocturnal sleep cycle resulting from LSD. Electroencephalogr Clin Neurophysiol 21(4):313–324. doi:10.1016/0013-4694(66)90037-X

    CAS  PubMed  Article  Google Scholar 

  72. Nichols DE (2004) Hallucinogens. Pharmacol Ther 101(2):131–181. doi:10.1016/j.pharmthera.2003.11.002

    CAS  PubMed  Article  Google Scholar 

  73. Nir Y, Tononi G (2010) Dreaming and the brain: from phenomenology to neurophysiology. Trends Cogn Sci 14(2):88–100. doi:10.1016/j.tics.2009.12.001

    PubMed  PubMed Central  Article  Google Scholar 

  74. Pace-Schott EF (2008) Serotonin and dreaming. In: Monti JM, Pandi-Perumal SR, Jacobs BL, Nutt DJ (eds) Serotonin and sleep: molecular, functional and clinical aspects. Birkhäuser Verlag, Basel, pp 307–324

    Google Scholar 

  75. Pace-Schott EF, Gersh T, Silvestri R, Stickgold R, Salzman C, Hobson JA (2001) SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects. J Sleep Res 10(2):129–142. doi:10.1046/j.1365-2869.2001.00249.x

    CAS  PubMed  Article  Google Scholar 

  76. Passie T, Halpern JH, Stichtenoth DO, Emrich HM, Hintzen A (2008) The pharmacology of lysergic acid diethylamide: a review. CNS neuroscience & therapeutics 14(4):295–314. doi:10.1111/j.1755-5949.2008.00059.x

    CAS  Article  Google Scholar 

  77. Persson B, Pettersson A, Hedner T (1987) Pharmacokinetics of ketanserin in patients with essential hypertension. Eur J Clin Pharmacol 32(3):259–265. doi:10.1007/BF00607573

    CAS  PubMed  Article  Google Scholar 

  78. Petri G, Expert P, Turkheimer F, Carhart-Harris R, Nutt D, Hellyer PJ, Vaccarino F (2014) Homological scaffolds of brain functional networks. J R Soc Interface 11(101):20140873. doi:10.1098/rsif.2014.0873

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  79. Pines M (1976) A psychoanalytic view of sleep. Postgrad Med J 52(603):26–31. doi:10.1136/pgmj.52.603.26

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  80. Pokorny T, Preller KH, Kraehenmann R, Vollenweider FX (2016) Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience. Eur Neuropsychopharmacol 26(4):756–766. doi:10.1016/j.euroneuro.2016.01.005

  81. Preller KH, Herdener M, Pokorny T, Planzer A, Kraehenmann R, Stämpfli P, Liechti ME, Seifritz E, Vollenweider FX (2017) The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation. Curr Biol 27(3):451–457. doi:10.1016/j.cub.2016.12.030

    CAS  PubMed  Article  Google Scholar 

  82. Quednow BB, Kometer M, Geyer MA, Vollenweider FX (2012) Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology 37(3):630–640. doi:10.1038/npp.2011.228

    CAS  PubMed  Article  Google Scholar 

  83. Rasmussen AR, Parnas J (2015) Anomalies of imagination and disordered self in schizophrenia spectrum disorders. Psychopathology 48(5):317–323. doi:10.1159/000431291

    PubMed  Article  Google Scholar 

  84. Rechtschaffen A (1978) The single-mindedness and isolation of dreams. Sleep 1(1):97–109. doi:10.1093/sleep/1.1.97

    CAS  PubMed  Article  Google Scholar 

  85. Rittenhouse CD, Stickgold R, Hobson JA (1994) Constraint on the transformation of characters, objects, and settings in dream reports. Conscious Cogn 3(1):100–113. doi:10.1006/ccog.1994.1007

    Article  Google Scholar 

  86. Roseman L, Sereno MI, Leech R, Kaelen M, Orban C, McGonigle J, Feilding A, Nutt DJ, Carhart-Harris RL (2016) LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion. Hum Brain Mapp 37(8):3031–3040. doi:10.1002/hbm.23224

    PubMed  Article  Google Scholar 

  87. Sandison RA (1954) Psychological aspects of the LSD treatment of the neuroses. J Ment Sci 100(419):508–515. doi:10.1192/bjp.100.419.508

    CAS  PubMed  Google Scholar 

  88. Sandison RA, Whitelaw JD (1957) Further studies in the therapeutic value of lysergic acid diethylamide in mental illness. J Ment Sci 103(431):332–343. doi:10.1192/bjp.103.431.332

    CAS  PubMed  Google Scholar 

  89. Sandison RA, Spencer AM, Whitelaw JD (1954) The therapeutic value of lysergic acid diethylamide in mental illness. J Ment Sci 100(419):491–507. doi:10.1192/bjp.100.419.491

    CAS  PubMed  Google Scholar 

  90. Sass LA, Byrom G (2015) Self-disturbance and the bizarre: on incomprehensibility in schizophrenic delusions. Psychopathology 48(5):293–300. doi:10.1159/000437210

    PubMed  Article  Google Scholar 

  91. Savage C (1955) Variations in ego feeling induced by d-lysergic acid diethylamide (LSD-25). Psychoanal Rev 42(1):1–16

    CAS  PubMed  Google Scholar 

  92. Scarone S, Manzone ML, Gambini O, Kantzas I, Limosani I, D'Agostino A, Hobson JA (2008) The dream as a model for psychosis: an experimental approach using bizarreness as a cognitive marker. Schizophr Bull 34(3):515–522. doi:10.1093/schbul/sbm116

    PubMed  Article  Google Scholar 

  93. Schmid Y, Enzler F, Gasser P, Grouzmann E, Preller KH, Vollenweider FX, Brenneisen R, Müller F, Borgwardt S, Liechti ME (2015) Acute effects of lysergic acid diethylamide in healthy subjects. Biol Psychiatry 78(8):544–553. doi:10.1016/j.biopsych.2014.11.015

    CAS  PubMed  Article  Google Scholar 

  94. Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ (1995) (1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT)2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 273(1):101–112

    CAS  PubMed  Google Scholar 

  95. Sessa B (2008) Is it time to revisit the role of psychedelic drugs in enhancing human creativity? J Psychopharmacol 22(8):821–827. doi:10.1177/0269881108091597

    CAS  PubMed  Article  Google Scholar 

  96. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The mini-International neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl. 20):22–33

  97. Sinke C, Halpern JH, Zedler M, Neufeld J, Emrich HM, Passie T (2012) Genuine and drug-induced synesthesia: a comparison. Conscious Cogn 21(3):1419–1434. doi:10.1016/j.concog.2012.03.009

    PubMed  Article  Google Scholar 

  98. Sio U, Monaghan P, Ormerod T (2013) Sleep on it, but only if it is difficult: effects of sleep on problem solving. Mem Cogn 41(2):159–166. doi:10.3758/s13421-012-0256-7

    Article  Google Scholar 

  99. Snyder SH, Faillace LA, Weingartner H (1969) A new psychotropic agent. Psychological and physiological effects of 2,5-dimethoxy-4-ethyl amphetamine (DOET) in man. Arch Gen Psychiatry 21(1):95–101. doi:10.1001/archpsyc.1969.01740190097014

    CAS  PubMed  Article  Google Scholar 

  100. Snyder SH, Weingartner H, Faillace LA (1971) DOET (2,5-dimethoxy-4-ethylamphetamine), a new psychotropic drug: effects of varying doses in man. Arch Gen Psychiatry 24(1):50–55. doi:10.1001/archpsyc.1971.01750070052006

    CAS  PubMed  Article  Google Scholar 

  101. Solms M (2000) Dreaming and REM sleep are controlled by different brain mechanisms. The Behavioral and brain sciences 23(6):843–850. doi:10.1017/S0140525X00003988

    CAS  PubMed  Article  Google Scholar 

  102. Spitzer M, Thimm M, Hermle L, Holzmann P, Kovar K-A, Heimann H, Gouzoulis-Mayfrank E, Kischka U, Schneider F (1996) Increased activation of indirect semantic associations under psilocybin. Biol Psychiatry 39(12):1055–1057. doi:10.1016/0006-3223(95)00418-1

    CAS  PubMed  Article  Google Scholar 

  103. Strassman RJ (1995) Human psychopharmacology of N,N-dimethyltryptamine. Behav Brain Res 73(1):121–124. doi:10.1016/0166-4328(96)00081-2

    CAS  Article  Google Scholar 

  104. Studerus E, Kometer M, Hasler F, Vollenweider FX (2011) Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. J Psychopharmacol 25(11):1434–1452. doi:10.1177/0269881110382466

    CAS  PubMed  Article  Google Scholar 

  105. Stumbrys T, Erlacher D, Malinowski P (2015) Meta-awareness during day and night. Imagination, Cognition and Personality 34(4):415–433. doi:10.1177/0276236615572594

    Article  Google Scholar 

  106. Sweat N, Bates L, Hendricks PS (2016) The associations of naturalistic classic psychedelic use, mystical experience, and creative problem solving. J Psychoactive Drugs 48(5):344–350. doi:10.1080/02791072.2016.1234090

    PubMed  Article  Google Scholar 

  107. Tagliazucchi E, Carhart-Harris R, Leech R, Nutt D, Chialvo DR (2014) Enhanced repertoire of brain dynamical states during the psychedelic experience. Hum Brain Mapp 35(11):5442–5456. doi:10.1002/hbm.22562

    PubMed  Article  Google Scholar 

  108. Terhune DB, Luke DP, Kaelen M, Bolstridge M, Feilding A, Nutt D, Carhart-Harris R, Ward J (2016) A placebo-controlled investigation of synaesthesia-like experiences under LSD. Neuropsychologia 88:28–34. doi:10.1016/j.neuropsychologia.2016.04.005

    PubMed  Article  Google Scholar 

  109. Thompson DF, Pierce DR (1999) Drug-induced nightmares. Ann Pharmacother 33(1):93–98. doi:10.1345/aph.18150

    CAS  PubMed  Article  Google Scholar 

  110. Torda C (1968) Contribution to serotonin theory of dreaming (LSD infusion). New York state journal of medicine 68(9):1135–1138

    CAS  PubMed  Google Scholar 

  111. Valle M, Maqueda AE, Rabella M, Rodríguez-Pujadas A, Antonijoan RM, Romero S, Alonso JF, Mañanas MÀ, Barker S, Friedlander P, Feilding A, Riba J (2016) Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans. Eur Neuropsychopharmacol 26(7):1161–1175. doi:10.1016/j.euroneuro.2016.03.012

    CAS  PubMed  Article  Google Scholar 

  112. Vollenweider FX, Geyer MA (2001) A systems model of altered consciousness: integrating natural and drug-induced psychoses. Brain Res Bull 56(5):495–507. doi:10.1016/S0361-9230(01)00646-3

    CAS  PubMed  Article  Google Scholar 

  113. Vollenweider FX, Leenders KL, Scharfetter C, Maguire P, Stadelmann O, Angst J (1997) Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology 16(5):357–372. doi:10.1016/S0893-133X(96)00246-1

    CAS  PubMed  Article  Google Scholar 

  114. Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9(17):3897–3902

    CAS  PubMed  Article  Google Scholar 

  115. Voss U, Holzmann R, Hobson A, Paulus W, Koppehele-Gossel J, Klimke A, Nitsche MA (2014) Induction of self awareness in dreams through frontal low current stimulation of gamma activity. Nat Neurosci 17(6):810–812. doi:10.1038/nn.3719

    CAS  PubMed  Article  Google Scholar 

  116. Wagner U, Gais S, Haider H, Verleger R, Born J (2004) Sleep inspires insight. Nature 427(6972):352–355. doi:10.1038/nature02223

  117. Weingartner H, Snyder SH, Faillace LA, Markley H (1970) Altered free associations: some cognitive effects of DOET (2,5-dimethoxy-4-ethylamphetamine). Behav Sci 15(4):297–303. doi:10.1002/bs.3830150402

    Article  Google Scholar 

  118. Weintraub W, Silverstein AB, Klee GD (1959) The effect of LSD on the associative processes. J Nerv Ment Dis 128(5):409–414

    CAS  PubMed  Article  Google Scholar 

  119. Williams J, Merritt J, Rittenhouse C, Hobson JA (1992) Bizarreness in dreams and fantasies. Conscious Cogn 1(2):172–185. doi:10.1016/1053-8100(92)90059-J

    Article  Google Scholar 

  120. Wittchen H-U, Fydrich T (1997) Strukturiertes Klinisches Interview für DSM-IV (SKID-I und SKID-II). Hogrefe, Göttingen

    Google Scholar 

Download references

Acknowledgements

This study was financially supported by grants from the Heffter Research Institute (1-190413), the Swiss Neuromatrix Foundation (2015-0103), the Usona Institute (2015-2056) and the Swiss National Science Foundation (SNSF, P2ZHP1_161626).

Author information

Affiliations

Authors

Corresponding author

Correspondence to Rainer Kraehenmann.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kraehenmann, R., Pokorny, D., Vollenweider, L. et al. Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation. Psychopharmacology 234, 2031–2046 (2017). https://doi.org/10.1007/s00213-017-4610-0

Download citation

Keywords

  • LSD
  • Ketanserin
  • 5-HT2A receptor
  • Guided mental imagery
  • Dreams
  • Cognitive bizarreness
  • Healthy subjects
  • Self-boundaries and cognitive control
  • Visual hallucinations